IDiyas

For the Inventor, By the Inventor

Malden, MA, United States of America

Magdi Moussa

USPTO Granted Patents = 7 

Average Co-Inventor Count = 6.1

ph-index = 2

Forward Citations = 41(Granted Patents)


Company Filing History:

goldMedal7 out of 104 
 
Arqule, Inc.
 patents

Years Active: 2010-2016

where 'Filed Patents' based on already Granted Patents

7 patents (USPTO):
1. 9447088 - Compositions and methods for treatment of cancer (2016-09-20),
2. 8754078 - Compositions and methods for treatment of cancer (2014-06-17),
3. 8563567 - Substituted heterocyclic compounds (2013-10-22),
4. 8541407 - Substituted benzo-pyrido-triazolo-diazepine compounds (2013-09-24),
5. 8377927 - Compositions and methods for treatment of cancer (2013-02-19),
6. 8273754 - Substituted 1H-pyrazolo[3,4-D]pyrimidine-6-amine compounds (2012-09-25),
7. 7713969 - Compositions and methods for treatment of cancer (2010-05-11),

Title: Magdi Moussa: Innovator in Cancer Treatment

Introduction

Magdi Moussa is a prominent inventor based in Malden, MA (US), known for his significant contributions to cancer treatment. With a total of 7 patents, he has dedicated his research to developing innovative methods and compositions that enhance therapeutic outcomes for patients suffering from cancer.

Latest Patents

Among his latest patents, Magdi Moussa has focused on compositions and methods for the treatment of cancer. His inventions relate to pyrroloquinolinyl-pyrrolidine-2,5-dione compounds used in combination with chemotherapeutic agents. These methods provide a novel approach to treating cell proliferative disorders, such as cancer, by administering a therapeutically effective amount of these compounds alongside effective doses of chemotherapeutic agents.

Career Highlights

Magdi Moussa has made a significant impact in the field of oncology through his work at Arqule, Inc. His innovative research has paved the way for new treatment options that could potentially improve patient outcomes in cancer therapy.

Collaborations

Throughout his career, Magdi has collaborated with notable colleagues, including Mark Anthony Ashwell and Jason J Hill. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking cancer treatments.

Conclusion

Magdi Moussa's contributions to cancer treatment through his innovative patents and collaborative efforts highlight his commitment to improving healthcare outcomes. His work continues to inspire advancements in the field of oncology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…